Development and evaluation of gastroresistant microspheres of pantoprazole

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 3, 2010, Pages 112-116

  Arya, Rajeshwar K K ^a   Juyal, Vijay ^a   Singh, Ripudaman ^b  

^a KUMAUN UNIVERSITY   (India)

^b BUNDELKHAND UNIVERSITY   (India)

Author keywords

Acid labile; Enteric coated; Gastroresistant; Microspheres; Pantoprazole; w o emulsification solvent evaporation

Indexed keywords

ALGINIC ACID; DOUBLE WALLED NANOTUBE; EUDRAGIT; MICROSPHERE; PANTOPRAZOLE; POLYMER;

ARTICLE; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; ENTERIC COATED TABLET; INTESTINE TRANSIT TIME; MUCOADHESION; PARTICLE SIZE;

EID: 77957554126     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Paul W. Pantoprazole: A New Proton Pump Inhibitor. Clinical Therapeutics 2000; 22: 1268-1293.
2. John H. The Proton-Pump Inhibitors: Similarities and Differences. Clinical Therapeutics 2000; 22(3): 266-280.
3. Katz P0. Pharmacologic Basis of Pantoprazole Dosing Current therapeutic research. Clinical Therapeutics 2000; 61(6) 8.
4. Geraldine M, Ferron J. Pharmacokinetics of Pantoprazole in Patients with Moderate and Severe Hepatic Dysfunction. Clinical therapeutics 2001; 23: 1180-1192.
5. Gennaro AR. Remington: The science and practice of pharmacy. 19th ed. (EP).Mack Publishing Company; 1995.
6. Tripathi KD. Essentials of medical pharmacology. 5thed. New Delhi: Jay Pee brothers: Medical publishers (P) ltd; 2003.
7. O'Donnell P, McGinity J. Preparation of Microspheres by the solvent evaporation technique. Adv. Drug Del. Rev 1997; 28: 25-42.
8. Yamagata Y, Misaki M, Kurokawa T, Taira K, Takada S. Preparation of a copoly (DL-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone. Int. J Pharm 2003; 251: 133-141.
9. Raffin RP. Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: Effect of the scale of production and process validation. Int. J Pharm 2006; 324: 10-18.
10. Raffin RP. Preparation Characterization and in-vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Euro. J Pharma 2006; 63(2): 198-204.
11. Daniel W, Packa B. Use of thermodynamic parameters for design of double walled microspheres fabrication methods Biomaterials 2006; 27(14): 2898-2906.
12. Rahman Z. Characterization of 5-Fluorouracil Microspheres for Colonic Delivery AAPS Pharm. Sci Tech 2006; 7(2).
13. Palmieri GF, Bonacucina G, Martelli S. Gastro-resistant microspheres containing ketoprofen. J. Microencapsulation 2002; 19(1): 111-119.
14. Kyekyoon Kim, Berkland C. Uniform double-walled polymer microspheres of controllable shell thickness. J. Cont. Rel 2001; 96: 101-111.
15. Benita S. Microencapsulation: Methods and Industrial Applications, New York: Marcel Dekker; 1996.
16. Chourasiya MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery system. J. Pharm. Sci. 2003; 6(1): 33-66.
17. Chi HW. Formulation and Characterization of Double-Walled Microspheres for the Sustained Release of A Highly Water Soluble Drug. J. Cont. Rel 2002; 83: 437-452.
18. Chi HW. Fabrication of double-walled microspheres for the sustained release of doxorubicin. J. Colloid and Interface Sci 2005; 291: 135-143.
19. Pekarek KJ, Jacob J S, Mathiowitz E. One-step preparation of double-walled Microspheres. Adv. Mater1994; 6(9): 684-687.
20. Pekarek KJ, Dyrud MJ, Ferrer K, Jong YS, Mathiowitz E. In vitro and in vivo degradation of double-walled polymer microspheres. J.Cont.Rel 1996; 40: 169-78.
21. Berkland C, Kim C, Pack D W. In-vitro degradation of polyanhydride/polyester core-shell double-wall microspheres. Int. J. Pharm 2005; 301(1-2): 294-303.
22. Sechoy O, Tissie G, Sebastian C, Trinquand C. A new long ophthalmic formulation of Cartelol containing Alginic acid. Int. J. Pharm 2000; 207(1-2): 109-116.
23. Tracy M, Ward K, Zhang Y. Factors affecting the degradation rate of poly (lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials1999; 20(11): 1057-1062.
24. Yang L, Chu JS, Fix JA. Colon-Specific Drug Delivery: New Approaches and In-Vitro/In-Vivo Evaluation. Int. J. Pharm 2002; 235: 1-15.
25. Zhu KJ, Zhang JX, Wang C, Yasuda H, Yamamoto K. Preparation and in vitro release behavior of 5-fluorouracil loaded Microspheres based on poly (L-lactide) and its carbonate copolymers. J. Microencapsulation 2003; 20(6): 731-743.
26. Mathiowitz E. localization of bovine serum albumin in double-walled microspheres. J. Cont. Rel 2004; 94(1): 163-175.
27. Gopferich A, Alonso MJ Langer R. Development and characterization of microencapsulated microspheres. Pharm. Research 1994; 11(11): 1568-1574.
28. Jain D, Panda AK, Majumdar DK. Eudragit S-100 Entrapped Insulin Microspheres for Oral Delivery. AAPS Pharm. Sci. Tech 2005; 6(1): E100-107.
29. Jimenez C, Zia H, Rhodes CT. Mucoadhesive drug delivery system, Drug develop. Ind. Pharm1993; 19: 143-150.
30. Lachman L, Liberman HA, Joseph KL. The theory and practice of Industrial pharmacy 3 rd ed. Varghese publication house; 1990.
31. Lee TH, Wang J, Wang C. Double-walled microspheres for the sustained release of a highly water soluble drug: Characterization and irradiation studies. J. Contr. Rel 2007; 83: 437-452.